Showing results (311-320 of 377) with videos related to
Sort By:
Pageof 38
Plos One|December 11, 2012
Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malariaDamien R Drew, Anthony N Hodder, Danny W Wilson, et al.Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.Immunity|March 19, 2015
Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malariaMichelle J Boyle, Linda Reiling, Gaoqian Feng, et al.Circulation Reports|November 11, 2025
Reproducibility, Accuracy, and Treatment Impact of Ischemia Severity Assessment From Coronary Angiography - An ORBITA Study AnalysisMasafumi Nakayama, Michael Foley, Christopher A Rajkumar, et al.Mabs|June 4, 2019
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4Katherine Griffiths, Uli Binder, William McDowell, et al.Scientific Reports|July 27, 2019
A suite of kinetically superior AEP ligases can cyclise an intrinsically disordered proteinKaren S Harris, Rosemary F Guarino, Ravindu S Dissanayake, et al.American Journal of Obstetrics and Gynecology|November 28, 2017
SMFM Special Report: Putting the "M" back in MFM: Addressing education about disparities in maternal outcomes and careLeslie Moroz, Laura E Riley, Mary D'Alton, et al.Journal of Pharmacological and Toxicological Methods|March 6, 2018
The evaluation of endpoint variability and implications for study statistical power and sample size in conscious instrumented dogsAlan Y Chiang, Brian D Guth, Michael K Pugsley, et al.The Journal of Biological Chemistry|December 17, 2003
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoitesOlivier Silvie, Jean-François Franetich, Stéphanie Charrin, et al.Plos One|September 28, 2011
A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720James S McCarthy, Joanne Marjason, Suzanne Elliott, et al.Pageof 38